Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for quantitatively determining a therapeutic TNF-alpha inhibitor

Method for quantitatively determining a therapeutic TNF-alpha inhibitor

US Patent 11953503 · Granted Apr 9, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Binding assay for the diagnosis of a heparin-induced thrombocytopenia2022
Activation assay for the diagnosis of a heparin-induced thrombocytopenia2022
Pre-saturation of the liver and subsequent administration of the contrast agent2020
Gold-based ablation electrode and method2020
Calibration of MRI systems using pre-defined concentrations of 19F isotopes as r2020
Methods and kits for determining von willebrand factor activity in the absence o2020
Methods and kits for determining von Willebrand factor activity in the absence o2018
Binding partners of the placental growth factor, especially antibodies directed 2016
Binding partners of the placental growth factor, especially antibodies directed 2016
Methods and kits for determining von willebrand factor activity in the absence o2015
Catalyst2015
Antibodies for determining the prothrombin fragment F2/F1+2 in a homogeneous imm2015